Skip to main content
NVDA-0.69%AAPL+0.50%GOOGL+1.34%MSFT+2.72%AMZN-0.62%TSM+0.60%SPCX-2.25%AVGO+2.77%TSLA-0.63%META+0.54%LLY+0.50%SKHY+13.30%BRK-B-0.49%MU-2.54%WMT-0.46%AMD+3.24%JPM+1.05%XOM+1.17%V-0.31%JNJ+0.86%ASMLa+1.33%MA+0.08%ABBV-0.14%INTC+1.91%1398.HK+2.46%CVX+0.46%0700.HK-2.09%ORCL+10.58%COST-0.95%CSCO-0.98%KO+0.60%PG-0.61%UNH-0.80%1816.HK+6.56%BAC+0.34%3988.HK+1.53%AMAT+5.07%AP2d+4.38%CAT+0.01%0857.HK+3.02%LRCX+5.39%HD-0.30%PM+0.01%0939.HK+2.27%DELL-1.64%GE+1.17%1288.HK+1.89%0005.HK+0.47%MS+1.81%HSBA.L+0.09%AUDNZD+1.64%NZDCAD-1.57%NZDUSD-1.49%NZDCHF-1.04%GBPNZD+1.03%EURNZD+0.91%NZDJPY-0.85%AUDJPY+0.79%CADJPY+0.74%EURAUD-0.71%USDJPY+0.65%EURCAD-0.64%GBPAUD-0.62%AUDCHF+0.60%EURUSD-0.58%GBPCAD-0.57%CADCHF+0.53%GBPUSD-0.48%USDCHF+0.45%GBPTRY+0.41%USDMXN+0.38%GBPHKD+0.32%GBPMXN-0.28%USDTRY+0.27%CHFJPY+0.21%NZDSGD-0.20%NZDMXN+0.20%EURCNH-0.19%EURSGD-0.18%GBPSGD-0.18%USDPLN+0.16%USDILS+0.16%AUDSGD-0.16%GBPJPY+0.16%USDZAR+0.15%PLNJPY-0.14%EURCHF-0.14%USDDKK+0.14%AUDUSD+0.14%USDCNH-0.14%EURHKD-0.14%CHFSGD-0.12%USDSEK+0.11%EURGBP-0.09%USDNOK+0.09%EURJPY+0.08%NOKJPY-0.07%USDCAD-0.07%USDTHB-0.06%SGDJPY+0.06%AUDCAD+0.05%USDHKD+0.05%EURCZK+0.05%EURNOK-0.05%GBPCHF-0.05%USDCOP-0.04%USDSGD-0.04%AUDNOK-0.03%CHFSEK+0.03%EURSEK-0.03%EURPLN+0.02%AUDDKK+0.02%GBPZAR+0.01%CHFNOK+0.01%EURDKK0.00%EURZAR0.00%GAGUSD-2.01%XAGUSD-2.01%XPTUSD-1.55%XAUUSD-0.79%GAUUSD-0.79%HG1-0.68%USOIL-0.49%XNGUSD+0.49%C1+0.39%S1-0.35%UKOIL-0.26%COTTON-0.10%BTCUSD-1.05%ETHUSD+22.55%USDTUSD0.00%XRPUSD+12.79%SOLUSD+16.94%TRXUSDT+0.16%ZECUSDT-4.81%DOGEUSD+18.62%XMRUSDT-2.54%LINKUSD+23.58%BCHUSDT-5.89%XLMUSD-1.28%UNIUSD-0.93%LTCUSD+16.21%SUIUSD-2.48%HBARUSDT-3.07%TONUSD+39.55%TAOUSDT-2.91%AAVEUSD-2.44%DOTUSDT-2.50%ICPUSDT-2.35%ONDOUSDT-3.40%WLDUSDT-6.49%ARBUSDT-1.38%JUPUSDT-4.31%ATOMUSDT-1.92%INJUSDT-3.55%STXUSDT-7.64%TIAUSDT-3.22%FETUSDT-2.46%PYTHUSDT-3.67%SEIUSDT-2.68%IMXUSDT-2.86%GRTUSDT-4.48%OPUSDT-3.87%WIFUSDT-0.83%IOTAUSDT-6.55%POLUSDT-1.92%AXSUSDT-4.71%EOSUSDT-1.33%FARTCOINUSDT-3.40%DYDXUSDT-1.70%GALAUSDT-1.53%ORDIUSDT-3.44%RONINUSDT-4.54%NOTUSDT-2.42%NVDA-0.69%AAPL+0.50%GOOGL+1.34%MSFT+2.72%AMZN-0.62%TSM+0.60%SPCX-2.25%AVGO+2.77%TSLA-0.63%META+0.54%LLY+0.50%SKHY+13.30%BRK-B-0.49%MU-2.54%WMT-0.46%AMD+3.24%JPM+1.05%XOM+1.17%V-0.31%JNJ+0.86%ASMLa+1.33%MA+0.08%ABBV-0.14%INTC+1.91%1398.HK+2.46%CVX+0.46%0700.HK-2.09%ORCL+10.58%COST-0.95%CSCO-0.98%KO+0.60%PG-0.61%UNH-0.80%1816.HK+6.56%BAC+0.34%3988.HK+1.53%AMAT+5.07%AP2d+4.38%CAT+0.01%0857.HK+3.02%LRCX+5.39%HD-0.30%PM+0.01%0939.HK+2.27%DELL-1.64%GE+1.17%1288.HK+1.89%0005.HK+0.47%MS+1.81%HSBA.L+0.09%AUDNZD+1.64%NZDCAD-1.57%NZDUSD-1.49%NZDCHF-1.04%GBPNZD+1.03%EURNZD+0.91%NZDJPY-0.85%AUDJPY+0.79%CADJPY+0.74%EURAUD-0.71%USDJPY+0.65%EURCAD-0.64%GBPAUD-0.62%AUDCHF+0.60%EURUSD-0.58%GBPCAD-0.57%CADCHF+0.53%GBPUSD-0.48%USDCHF+0.45%GBPTRY+0.41%USDMXN+0.38%GBPHKD+0.32%GBPMXN-0.28%USDTRY+0.27%CHFJPY+0.21%NZDSGD-0.20%NZDMXN+0.20%EURCNH-0.19%EURSGD-0.18%GBPSGD-0.18%USDPLN+0.16%USDILS+0.16%AUDSGD-0.16%GBPJPY+0.16%USDZAR+0.15%PLNJPY-0.14%EURCHF-0.14%USDDKK+0.14%AUDUSD+0.14%USDCNH-0.14%EURHKD-0.14%CHFSGD-0.12%USDSEK+0.11%EURGBP-0.09%USDNOK+0.09%EURJPY+0.08%NOKJPY-0.07%USDCAD-0.07%USDTHB-0.06%SGDJPY+0.06%AUDCAD+0.05%USDHKD+0.05%EURCZK+0.05%EURNOK-0.05%GBPCHF-0.05%USDCOP-0.04%USDSGD-0.04%AUDNOK-0.03%CHFSEK+0.03%EURSEK-0.03%EURPLN+0.02%AUDDKK+0.02%GBPZAR+0.01%CHFNOK+0.01%EURDKK0.00%EURZAR0.00%GAGUSD-2.01%XAGUSD-2.01%XPTUSD-1.55%XAUUSD-0.79%GAUUSD-0.79%HG1-0.68%USOIL-0.49%XNGUSD+0.49%C1+0.39%S1-0.35%UKOIL-0.26%COTTON-0.10%BTCUSD-1.05%ETHUSD+22.55%USDTUSD0.00%XRPUSD+12.79%SOLUSD+16.94%TRXUSDT+0.16%ZECUSDT-4.81%DOGEUSD+18.62%XMRUSDT-2.54%LINKUSD+23.58%BCHUSDT-5.89%XLMUSD-1.28%UNIUSD-0.93%LTCUSD+16.21%SUIUSD-2.48%HBARUSDT-3.07%TONUSD+39.55%TAOUSDT-2.91%AAVEUSD-2.44%DOTUSDT-2.50%ICPUSDT-2.35%ONDOUSDT-3.40%WLDUSDT-6.49%ARBUSDT-1.38%JUPUSDT-4.31%ATOMUSDT-1.92%INJUSDT-3.55%STXUSDT-7.64%TIAUSDT-3.22%FETUSDT-2.46%PYTHUSDT-3.67%SEIUSDT-2.68%IMXUSDT-2.86%GRTUSDT-4.48%OPUSDT-3.87%WIFUSDT-0.83%IOTAUSDT-6.55%POLUSDT-1.92%AXSUSDT-4.71%EOSUSDT-1.33%FARTCOINUSDT-3.40%DYDXUSDT-1.70%GALAUSDT-1.53%ORDIUSDT-3.44%RONINUSDT-4.54%NOTUSDT-2.42%
TT

Trevi Therapeutics, Inc. (TRVI)

NASDAQ • Healthcare

$13.52
+$0.16 (+1.3%)
Market closed

Last close at October 28, 2026 at 20:00 UTC

Open$13.26
Day Range$13.21 - $13.54
Avg. Volume (3M)2.7M
Market Cap$1.9B
52 Week Range
$9.82$20.22
Next EarningsIn 14 daysNov 12, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$51.1M
EPS (TTM)
-$0.34
ROA (TTM)
-15.46%
Current Ratio
37.28
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+40.0%Q1 2026-$0.06
-28.6%Q2 2026-$0.09
-0.5%Q3 2026-$0.11
Next

Nov 12

in 14 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -0.5%

Trevi Therapeutics’ preliminary results for the second fiscal quarter of 2026 showed a wider year-over-year loss, with EPS coming in in line with consensus; the company reported the quarter ended June 30, 2026 on August 6, 2026. EPS was -$0.110 versus the -$0.109 estimate (difference -$0.001, in line), and was down ~22% from -$0.090 a year ago. Net income was -$17.8 million, down ~45% from -$12.3 million a year ago, while operating income stood at -$20.5 million. Cash burn remained evident, with negative operating cash flow of -$17.4 million during the quarter. Consensus for the next period calls for EPS of -$0.130.

Next report — what to expect

Trevi Therapeutics, Inc. (TRVI) is scheduled to report earnings on November 12, 2026. Wall Street is looking for consensus EPS of -$0.132. The company has beaten EPS in 5 of its 8 most recent quarters, making the EPS line a key focal point heading into the print.

View full earnings history

About Trevi Therapeutics, Inc.

Trevi Therapeutics, Inc. is a NASDAQ-listed biotechnology company developing Haduvio for neurologically mediated conditions. The company is an early-stage healthcare business rather than a commercial drug seller, with its work centered on a single oral therapy candidate from its base in New Haven, Connecticut.

Name
Trevi Therapeutics, Inc.
CEO
Jennifer L. Good
Website
www.trevitherapeutics.com
Industry
Healthcare
Year Founded
2011
Employees
34

Today's Snapshot

AI-generated

TRVI closed 1.3% higher at 13.52, while its sector was flat. Volume was about two-thirds of its usual level.

Trading Volume

Below 10d avg (1.7M)

1M

vs S&P 500 Today

Outperforming Market

+1.00%

Updated: October 28, 2026 at 20:19 UTC

Technical Indicators

2 Buy3 Neutral3 Sell
TRVI shows mixed short-term strength but clear longer-term weakness, supporting the sell stance. The stock sits just above the 10- and 20-period averages while trading below most medium and long-term moving averages, and momentum readings are mildly positive even as MACD remains slightly negative and RSI is neutral. Trend strength is elevated, with ADX indicating a firm directional bias to the downside, and on-balance volume is weak, suggesting distribution. Volatility is moderate with a modest ATR relative to price, and the pivot sits slightly beneath the market. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$12.91 - $14.96
    Sell
  • RSI (14)50.49
    Neutral
  • Stochastic %K (14, 3, 3)79.06
    Neutral
  • MACD Level (12, 26)-0.51
    Neutral

Peers & Related Assets

LQDALiquidia Corporation
$45.72+0.6%
ACADAcadia Pharmaceuticals Inc.
$20.32+0.7%
RAPPRapport Therapeutics, Inc. Common Stock
$22.5-18.3%
TBPHTheravance Biopharma Inc
$17.030.0%
UPBUpstream Bio, Inc.
$2.98+6.8%
LXRXLexicon Pharmaceuticals, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.